Coronary revascularization improves long-term prognosis in diabetic and nondiabetic end-stage renal disease

Circ J. 2002 Jun;66(6):595-9. doi: 10.1253/circj.66.595.

Abstract

To test the hypothesis that coronary revascularization improves long-term prognosis in patients with hemodialysis, 80 of 121 patients (66%) on maintenance hemodialysis who had undergone initial coronary angiography had bypass surgery, catheter angioplasty, or both between 1983 and 1999. Multivessel disease was more frequent (p=0.01) and the duration of hemodialysis therapy was shorter (p=0.01) in patients with diabetes (n=61), than in nondiabetic patients (n=60). Of the patients who underwent revascularization, complete revascularization was achieved in 75% of those with diabetic nephropathy (30/40) and 83% in a similar number of nondiabetic patients (33/40). The 5-year survival rate from initiation of hemodialysis was 79% in diabetic and 96% in non-diabetic patients (p<0.01), exceeding published Japanese (53% vs 70%) and US (26% vs 60%) survival rates. When survival was studied from the date of revascularization, predictors of outcome were age and achievement of complete revascularization. Surprisingly, diabetes was not a predictor of survival outcome. Complete revascularization improves long-term survival in both diabetic and nondiabetic patients.

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary
  • Diabetic Nephropathies / complications
  • Diabetic Nephropathies / therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Hypercholesterolemia / complications
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Myocardial Revascularization* / mortality
  • Prognosis
  • Renal Dialysis*
  • Retrospective Studies
  • Risk Factors
  • Smoking
  • Survival Analysis
  • Time Factors
  • Treatment Outcome